Correction: Aspartames Alter Pharmacokinetics Parameters of Erlotinib and Gefitinib and Elevate Liver Enzymes in Wistar Rats (Pharmaceuticals, (2022), 15, 11, (1400), 10.3390/ph15111400)

In the original publication [1], there was a mistake in Figure 5: There was no drastic change in body weight between day 0 and day 1. Day 0 data were entered mistakenly as zero instead of the actual weight prior to administration. The text on the y axis of the graph should have indicated body weight and not % body weight. The corrected Figure 5 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.